Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bispecific antibodies
Pharma
Akeso CEO touts biliary tract win, counters ivonescimab debate
The Akeso CEO also pushed back against new debates around dataset fluctuations in NSCLC.
Angus Liu
Aug 26, 2026 11:11am
Jazz’s Ziihera nets FDA nod in first-line HER2+ stomach cancer
Aug 25, 2026 11:06am
J&J bispecific combo delivers 89% PFS benefit in myeloma
Jul 23, 2026 8:30am
Summit updates ivonescimab survival data ahead of PDUFA
Jul 22, 2026 10:58am
Why Legend Biotech stock fell 10% despite record Carvykti sales
Jul 20, 2026 11:11am
BioNTech lays commercial groundwork for PD-L1xVEGF via HER2 ADC
Jul 9, 2026 2:17pm
